Ebola antibodies detected in DRC residents a year before 2018 outbreak

The 2018 DRC Ebola outbreak killed nearly 2,300 people, with study subjects showing prior asymptomatic exposure.
Not everyone exposed dies. Spillover doesn't always cause outbreaks.
Researchers found Ebola antibodies in people who survived exposure, suggesting the virus circulates more quietly than outbreak narratives suggest.

Before Ebola announced itself with catastrophic force in eastern Congo in 2018, it had already passed quietly through human lives, leaving antibodies where death might have been expected. Researchers testing pre-outbreak blood samples in North Kivu Province found that one in ten people carried evidence of past Ebola exposure — without recorded illness, without alarm. This discovery, led by scientists at UC Davis and Columbia University, asks us to reconsider what we think we know about how dangerous viruses move between animals and people, and how much of that movement remains invisible to us until it is too late.

  • A virus that kills with terrifying visibility had been circulating silently for at least a year before the 2018 DRC outbreak claimed nearly 2,300 lives — and no one knew.
  • Ten percent of pre-outbreak blood samples carried Ebola antibodies, suggesting that spillover from wildlife to humans may be far more frequent, and far less lethal in every instance, than outbreak records have ever shown.
  • Women faced significantly higher exposure risk, their daily labor — preparing food, tending animals, nursing the sick — placing them at the precise intersections where viruses cross species.
  • Researchers also identified the first known human antibodies to Bombali ebolavirus, a bat-borne sixth species of Ebola, expanding the map of viral threat in ways science is only beginning to chart.
  • Surveillance programs like USAID PREDICT and Gorilla Doctors are now pressing for continuous monitoring between outbreaks, arguing that the invisible transmissions are where prevention must begin.

In the year before Ebola killed nearly 2,300 people in eastern Congo, the virus was already moving through the population undetected. Researchers testing blood samples from 272 people who sought medical care in North Kivu Province's Rutshuru Health Zone found that one in ten carried Ebola antibodies — evidence of exposure to a pathogen that should have announced itself with fever and death. Instead, these individuals had survived contact, or perhaps never fallen ill at all.

The study, published in One Health Outlook and led by UC Davis and Columbia University scientists, challenges the familiar picture of Ebola as a virus that arrives suddenly and kills visibly. It suggests that either early cases of the 2018 outbreak went unrecognized, or that animal-to-human spillover occurs far more often than the lethal clusters we track. "Not everyone who is exposed dies," said lead author Tracey Goldstein of UC Davis's One Health Institute. "To prevent outbreaks, we need a better understanding of what's happening between them."

The research also documented the first known human antibodies to Bombali ebolavirus — a sixth Ebola species discovered in bats in Sierra Leone in 2018 — confirming that bat-to-human transmission has occurred at least once, and that the virus family is more widely distributed than previously understood.

Questionnaires revealed a striking pattern: women showed significantly higher exposure rates than men, likely because their roles in food preparation, livestock care, and tending to sick family members place them in repeated contact with animals and their fluids. Jean-Paul Kabemba Lukusa of Gorilla Doctors, who coordinated the human surveillance, saw the findings as reinforcement for community prevention work already underway — urging people to limit contact with wild animals and maintain hygiene practices.

What this research ultimately reveals is an epidemiology more complex than outbreak narratives capture. The virus does not arrive from nowhere. It circulates in ways we do not yet fully see, touching people who survive it, leaving antibodies as silent testimony. Understanding those invisible transmissions — the exposures that do not kill, the contacts that do not ignite epidemics — may be the most important frontier in preventing the ones that do.

In the year before Ebola swept through eastern Congo in 2018, killing nearly 2,300 people, the virus was already moving through the population in ways no one had detected. Researchers testing blood samples from 272 people who sought medical care in the Rutshuru Health Zone of North Kivu Province found that one in ten carried antibodies to Ebola—evidence of past exposure to a virus that should have announced itself with fever, bleeding, and death. Instead, these people had survived contact with the pathogen, or perhaps never became sick at all.

The discovery, published in One Health Outlook and led by scientists at UC Davis and Columbia University, upends a simple picture of how Ebola moves through human populations. It suggests either that early cases of the 2018 outbreak went unrecognized, or that spillover from animals to humans happens far more often than the dramatic, lethal clusters we know about. "These are lethal diseases, but there's a range of severity," said Tracey Goldstein, the study's lead author and associate director of the One Health Institute at UC Davis's School of Veterinary Medicine. "Not everyone who is exposed dies. Spillover doesn't always cause lethal outbreaks. To prevent outbreaks, we need a better understanding of what's happening between them."

The research also documented the first human case of antibodies to Bombali ebolavirus, a sixth species of Ebola virus discovered in bats in Sierra Leone in 2018. That finding alone signals that the virus family is larger and more widely distributed than previously known, and that transmission from bats to people has occurred at least once—possibly more.

When researchers administered questionnaires alongside the blood tests, a pattern emerged: women showed significantly higher rates of exposure than men. The difference likely reflects the work women do in these communities—preparing food, tending livestock, caring for sick family members. These are the hands-on roles that bring people into contact with animals and their fluids, the pathways through which viruses jump species.

Jean-Paul Kabemba Lukusa, a medical technologist with Gorilla Doctors who coordinated the human surveillance for this study, saw the findings as validation of the prevention work already underway. "It shows that people may become exposed to Ebola virus without becoming ill," he said. "It helps reinforce the work we do to explain to people how important it is to limit direct contact with wild animals and to follow hygiene and safety best practices."

The study was part of a larger effort by Gorilla Doctors and the USAID PREDICT Project to track viruses circulating among both wildlife and humans in the region. Kirsten Gilardi, who directs both the UC Davis Karen C. Drayer Wildlife Health Center and the Gorilla Doctors program—which provides veterinary care to mountain and eastern lowland gorillas across Rwanda, Uganda, and the DRC—framed the implications clearly: "These findings suggest there are more spillover events than we realize. This may not happen once in a while and then the virus disappears. Preventing spillover means understanding and minimizing high-risk human-to-wildlife interactions."

What emerges from this work is a more complicated epidemiology than outbreak narratives typically capture. The virus does not arrive suddenly from nowhere. It circulates in ways we do not yet fully see, touching people who survive it, who carry the antibodies as silent evidence. Understanding those invisible transmissions—the exposures that do not kill, the contacts that do not spark epidemics—may be the key to stopping the ones that do.

These are lethal diseases, but there's a range of severity. Not everyone who is exposed dies. To prevent outbreaks, we need a better understanding of what's happening between them.
— Tracey Goldstein, lead author and associate director of the One Health Institute at UC Davis
These findings suggest there are more spillover events than we realize. Preventing spillover means understanding and minimizing high-risk human-to-wildlife interactions.
— Kirsten Gilardi, director of the UC Davis Karen C. Drayer Wildlife Health Center and Gorilla Doctors program
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

So these people had Ebola antibodies but didn't get sick? How is that possible?

Model

It means they were exposed to the virus, their immune system fought it off, and they survived. We don't know if they had mild symptoms they didn't recognize or if their bodies simply contained the infection before it could spread. Either way, they lived.

Inventor

And this was happening a full year before the outbreak that killed thousands?

Model

Yes. Which means the virus was already in the community, moving through it in ways that didn't trigger alarms. Either we missed those early cases entirely, or exposure is just more common than we thought—most of the time it doesn't become an outbreak.

Inventor

Why would women be at higher risk?

Model

They're the ones preparing food, handling animals, caring for sick family members. Those are the moments when you touch blood, fluids, tissue. That's where the virus crosses over.

Inventor

So this isn't really about Ebola being more dangerous than we thought?

Model

No, it's the opposite. It's about Ebola being more present than we thought, but also less uniformly lethal. The virus is out there constantly. Most of the time it doesn't kill. Understanding those quiet transmissions might be how we stop the loud ones.

Inventor

What changes because of this study?

Model

We have to stop thinking of spillover as rare events. We have to watch continuously, not just during crises. And we have to understand the specific behaviors and contacts that matter—who touches what, when, how often. That's where prevention actually lives.

Fale Conosco FAQ